X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13047) 13047
Book / eBook (17) 17
Magazine Article (15) 15
Newsletter (12) 12
Newspaper Article (11) 11
Book Chapter (5) 5
Conference Proceeding (1) 1
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12615) 12615
laryngeal neoplasms - pathology (9359) 9359
male (8378) 8378
middle aged (6936) 6936
female (6771) 6771
science & technology (6188) 6188
life sciences & biomedicine (6098) 6098
aged (5840) 5840
adult (4776) 4776
laryngeal neoplasms - surgery (3990) 3990
carcinoma, squamous cell - pathology (3826) 3826
otorhinolaryngology (3156) 3156
neoplasm staging (2710) 2710
aged, 80 and over (2002) 2002
retrospective studies (1973) 1973
prognosis (1947) 1947
surgery (1673) 1673
laryngeal neoplasms - radiotherapy (1601) 1601
laryngeal neoplasms - diagnosis (1576) 1576
oncology (1571) 1571
larynx (1538) 1538
carcinoma, squamous cell - surgery (1432) 1432
larynx - pathology (1419) 1419
treatment outcome (1414) 1414
laryngectomy (1397) 1397
laryngeal cancer (1341) 1341
laryngeal neoplasms - mortality (1334) 1334
follow-up studies (1321) 1321
lymphatic metastasis (1186) 1186
laryngeal neoplasms - metabolism (1131) 1131
cancer (1130) 1130
laryngeal neoplasms - therapy (1084) 1084
squamous cell carcinoma (1045) 1045
immunohistochemistry (974) 974
survival rate (879) 879
laryngeal neoplasms - genetics (873) 873
laryngoscopy (843) 843
laryngectomy - methods (823) 823
carcinoma, squamous cell - mortality (807) 807
carcinoma, squamous cell - metabolism (794) 794
diagnosis, differential (794) 794
carcinoma, squamous cell - radiotherapy (791) 791
pathology (755) 755
neoplasm invasiveness (740) 740
combined modality therapy (738) 738
glottis - pathology (728) 728
tomography, x-ray computed (716) 716
radiotherapy (687) 687
head and neck neoplasms - pathology (683) 683
biopsy (674) 674
laryngeal neoplasms (638) 638
laryngeal neoplasms - diagnostic imaging (632) 632
neoplasm recurrence, local (621) 621
carcinoma, squamous cell - genetics (619) 619
care and treatment (618) 618
vocal cords - pathology (617) 617
analysis (610) 610
adolescent (609) 609
risk factors (609) 609
time factors (604) 604
medicine & public health (585) 585
carcinoma - pathology (570) 570
disease-free survival (568) 568
glottis (567) 567
laryngeal neoplasms - complications (558) 558
pharyngeal neoplasms - pathology (532) 532
laryngeal neoplasms - drug therapy (531) 531
child (513) 513
animals (510) 510
carcinoma, squamous cell - secondary (510) 510
hypopharyngeal neoplasms - pathology (502) 502
neoplasm recurrence, local - pathology (496) 496
medicine, research & experimental (494) 494
research & experimental medicine (493) 493
tumors (486) 486
otolaryngology (484) 484
neck dissection (482) 482
survival analysis (478) 478
prospective studies (468) 468
cell line, tumor (467) 467
lymph nodes - pathology (467) 467
carcinoma, squamous cell - therapy (453) 453
research (441) 441
carcinoma (422) 422
laryngeal neoplasms - epidemiology (420) 420
radiotherapy dosage (418) 418
laryngeal carcinoma (410) 410
neoplasm metastasis (410) 410
carcinoma, squamous cell - diagnosis (406) 406
radiology, nuclear medicine & medical imaging (404) 404
metastasis (392) 392
papilloma - pathology (391) 391
neck (387) 387
glottis - surgery (381) 381
head and neck cancer (371) 371
diagnosis (369) 369
magnetic resonance imaging (349) 349
health aspects (338) 338
mouth neoplasms - pathology (337) 337
patients (333) 333
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Course Reserves (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10638) 10638
Chinese (790) 790
German (579) 579
Polish (389) 389
Russian (373) 373
Spanish (353) 353
French (326) 326
Italian (228) 228
Japanese (146) 146
Turkish (40) 40
Czech (31) 31
Portuguese (27) 27
Hungarian (20) 20
Serbian (19) 19
Danish (17) 17
Romanian (16) 16
Croatian (13) 13
Dutch (12) 12
Slovak (10) 10
Hebrew (9) 9
Norwegian (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 9, pp. 1566 - 1575
BACKGROUND Human papillomavirus (HPV) is a well‐established prognostic marker for oropharyngeal squamous cell cancer (OPSCC). Because of the limited numbers of... 
human papillomavirus (HPV) | head and neck squamous cell cancer (HNSCC) | p16 | race | sex | oropharyngeal squamous cell cancer (OPSCC) | prognosis | Life Sciences & Biomedicine | Oncology | Science & Technology | Oropharyngeal Neoplasms - ethnology | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prognosis | Asian Americans - statistics & numerical data | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Nasopharyngeal Neoplasms - ethnology | Nasopharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - mortality | Hispanic Americans - statistics & numerical data | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - ethnology | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Mouth Neoplasms - ethnology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Head and Neck Neoplasms - ethnology | Laryngeal Neoplasms - ethnology | Female | Papillomavirus Infections - virology | Retrospective Studies | Repressor Proteins - metabolism | Oncogene Proteins, Viral - metabolism | Ethnic Groups - statistics & numerical data | Papillomavirus Infections - epidemiology | Proportional Hazards Models | European Continental Ancestry Group - statistics & numerical data | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Mouth Neoplasms - mortality | Human papillomavirus 16 - metabolism | Head and Neck Neoplasms - pathology | African Americans - statistics & numerical data | Papillomavirus E7 Proteins - metabolism | Laryngeal Neoplasms - mortality | Sex Factors | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Mouth Neoplasms - pathology | Head and Neck Neoplasms - mortality | Neoplasm Staging | DNA, Viral | Human papillomavirus 16 - genetics | Laryngeal Neoplasms - virology | Complications and side effects | Care and treatment | DNA | Head and neck cancer | Research | Papillomavirus infections | Risk factors | Sex | Risk | Population studies | mRNA | Nasopharynx | Human papillomavirus | Race | Larynx | Deoxyribonucleic acid--DNA | Squamous cell carcinoma | Head | Adjustment | Mortality | Health risks | Hazards | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Survival | Oral cavity | Tobacco | Medical prognosis | Men | Health hazards | Health risk assessment | Hispanics | Cancer | Tumors
Journal Article
European Annals of Otorhinolaryngology, Head and Neck Diseases, ISSN 1879-7296, 2012, Volume 130, Issue 2, pp. 107 - 112
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1078 - 1085
Purpose To compare the temporal lymph node (LN) regression and regional control (RC) after primary chemoradiation therapy/radiation therapy in human... 
Radiology | Hematology, Oncology and Palliative Medicine | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Multivariate Analysis | Head and Neck Neoplasms - virology | Lymph Nodes - pathology | Hypopharyngeal Neoplasms - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Laryngeal Neoplasms - pathology | Lymph Nodes - radiation effects | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Adult | Female | Papillomavirus Infections - virology | Remission Induction - methods | Oropharyngeal Neoplasms - drug therapy | Laryngeal Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Organ Size | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Lymph Nodes - virology | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Hypopharyngeal Neoplasms - pathology | Aged | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Head and Neck Neoplasms - surgery | Cohort Studies | Laryngeal Neoplasms - virology | Neck Dissection | Sects | Care and treatment | Radiotherapy | Nuclear radiation | Papillomavirus infections | Cancer | HEAD | MULTIVARIATE ANALYSIS | NEOPLASMS | LYMPH NODES | POSITRON COMPUTED TOMOGRAPHY | CHARGES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | LARYNX | HAZARDS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 5, pp. 1360 - 1368
Purpose The aim of this study was to investigate prospectively the weekly volume changes in the target volumes and organs at risk and the resulting dosimetric... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Volume changes | Chemo-IMRT | Dosimetric changes | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Laryngeal Neoplasms - radiotherapy | Prospective Studies | Humans | Oropharyngeal Neoplasms - diagnostic imaging | Spinal Cord - radiation effects | Laryngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - radiotherapy | Fluorouracil - administration & dosage | Time Factors | Laryngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - drug therapy | Brain Stem - radiation effects | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - drug therapy | Parotid Gland - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Tumor Burden | Head and Neck Neoplasms - pathology | Radiography | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Parotid Gland - radiation effects | Hypopharyngeal Neoplasms - pathology | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Hypopharyngeal Neoplasms - diagnostic imaging | Care and treatment | Chemotherapy | Oncology, Experimental | Radiation | Research | Radiotherapy | Cancer | TOMOGRAPHY | HEAD | DIAGNOSTIC TECHNIQUES | NEOPLASMS | RADIATION DOSES | MEDICINE | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | CAT SCANNING | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | BODY | COMBINED THERAPY | RADIOLOGY
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 05/2014, Volume 89, Issue 1, pp. 13 - 20
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 67, pp. 174 - 182
Abstract Aim The aim is to evaluate the impact of cisplatin dose modification on outcomes of human papillomavirus (HPV)-related (HPV+) and HPV-unrelated (HPV−)... 
Hematology, Oncology and Palliative Medicine | Head and neck cancer | Human papillomavirus | Survival | Chemoradiotherapy | Cisplatin | Life Sciences & Biomedicine | Oncology | Science & Technology | Oropharyngeal Neoplasms - therapy | Head and Neck Neoplasms - virology | Hypopharyngeal Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Case-Control Studies | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Aged, 80 and over | Adult | Female | Retrospective Studies | Papillomavirus Infections - complications | Head and Neck Neoplasms - therapy | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Oropharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - complications | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Carcinoma, Squamous Cell - complications | Hypopharyngeal Neoplasms - pathology | Radiotherapy, Conformal | Head and Neck Neoplasms - complications | Aged | Hypopharyngeal Neoplasms - complications | Neoplasm Staging | Laryngeal Neoplasms - complications | Laryngeal Neoplasms - virology | Radiotherapy, Intensity-Modulated | Papillomaviruses | Antimitotic agents | Squamous cell carcinoma | Antineoplastic agents | Papillomavirus infections
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 126 - 134
Purpose To perform a comprehensive cognitive function (CF) assessment in patients who were relapse free after curative intent radiotherapy (RT) or... 
Radiology | Hematology, Oncology and Palliative Medicine | Squamous cell carcinoma of the head and neck | Chemotherapy | Neuropsychological testing | Radiotherapy | Cognitive dysfunction | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Laryngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - radiotherapy | Cerebellum - radiation effects | Prospective Studies | Humans | Middle Aged | Male | Pharyngeal Neoplasms - drug therapy | Antineoplastic Agents - administration & dosage | Cognition - physiology | Laryngeal Neoplasms - drug therapy | Neoplasms, Squamous Cell - pathology | Carcinoma - drug therapy | Carcinoma - blood | Affect - physiology | Head and Neck Neoplasms - drug therapy | Cognition - drug effects | Neoplasms, Squamous Cell - blood | Head and Neck Neoplasms - pathology | Carcinoma, Squamous Cell | Neuropsychological Tests | Cognition Disorders - diagnosis | Memory Disorders - etiology | Hypopharyngeal Neoplasms - pathology | Quality of Life | Pharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - drug therapy | Temporal Lobe - drug effects | Laryngeal Neoplasms - blood | Cerebellum - drug effects | Hypopharyngeal Neoplasms - blood | Cisplatin - administration & dosage | Feasibility Studies | Laryngeal Neoplasms - pathology | Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasms - blood | Antineoplastic Agents - adverse effects | Cognition Disorders - etiology | Neoplasms, Squamous Cell - drug therapy | Neoplasms, Squamous Cell - radiotherapy | Female | Carcinoma - pathology | Cognition - radiation effects | Affect - drug effects | Pharyngeal Neoplasms - blood | Affect - radiation effects | Carcinoma - radiotherapy | Combined Modality Therapy - adverse effects | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Cisplatin - adverse effects | Aged | Combined Modality Therapy - methods | Temporal Lobe - radiation effects | Care and treatment | Squamous cell carcinoma | Cancer | BODY FLUIDS | HEAD | NERVOUS SYSTEM | RADIATION DOSES | MEDICINE | THERAPY | CEREBELLUM | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY | BRAIN | RADIOLOGY | BLOOD | NEOPLASMS | BIOLOGICAL MATERIALS | CENTRAL NERVOUS SYSTEM | STANDARD OF LIVING | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | DOSES | CARCINOMAS | NECK | DOSIMETRY | BODY | MATERIALS
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 03/2014, Volume 88, Issue 4, pp. 806 - 813
Purpose To investigate, in a large cohort of patients, the immunophenotypic and clinical differences of nasal and extranasal extranodal nasal-type natural... 
Radiology | Hematology, Oncology and Palliative Medicine | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Doxorubicin - therapeutic use | Humans | Middle Aged | Ki-67 Antigen - metabolism | Male | Pharyngeal Neoplasms - drug therapy | Young Adult | Pharyngeal Neoplasms - immunology | Aged, 80 and over | Antigens, Neoplasm - metabolism | Laryngeal Neoplasms - drug therapy | Immunophenotyping - methods | Lymphoma, Extranodal NK-T-Cell - immunology | Child | Nose Neoplasms - pathology | Survival Rate | Lymphatic Metastasis | Laryngeal Neoplasms - immunology | Pharyngeal Neoplasms - mortality | Lymphoma, T-Cell - drug therapy | Lymphoma, Extranodal NK-T-Cell - pathology | Adolescent | Vincristine - therapeutic use | Lymphoma, Extranodal NK-T-Cell - mortality | Pharyngeal Neoplasms - pathology | Tongue Neoplasms - immunology | Prednisone - therapeutic use | Cohort Studies | Nose Neoplasms - mortality | Lymphoma, T-Cell - immunology | Prognosis | Cyclophosphamide - therapeutic use | Tongue Neoplasms - drug therapy | Laryngeal Neoplasms - pathology | Lymphoma, Extranodal NK-T-Cell - drug therapy | Doxorubicin - analogs & derivatives | Adult | Female | Retrospective Studies | Severity of Illness Index | Tongue Neoplasms - mortality | CD56 Antigen - metabolism | Tracheal Neoplasms - pathology | Tracheal Neoplasms - mortality | Tongue Neoplasms - pathology | Tracheal Neoplasms - immunology | Laryngeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Nose Neoplasms - drug therapy | Lymphoma, T-Cell - pathology | Aged | Lymphoma, T-Cell - mortality | Nose Neoplasms - immunology | Neoplasm Staging | Medical colleges | Nuclear radiation | Lymphomas | LYMPHOMAS | DIAGNOSIS | PATIENTS | RADIOLOGY AND NUCLEAR MEDICINE | LYMPH NODES | NOSE
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 1823 - 1830
Purpose The tumor volume has been established as a significant predictor of outcomes among patients with head-and-neck cancer undergoing radiotherapy alone.... 
Radiology | Hematology, Oncology and Palliative Medicine | Primary tumor volume | Head and neck cancer | TNM staging | Tumor recurrence | Chemoradiotherapy | Survival | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Oropharyngeal Neoplasms - therapy | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Oropharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - mortality | Laryngeal Neoplasms - diagnostic imaging | Male | Carcinoma, Squamous Cell - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Chemoradiotherapy - methods | Head and Neck Neoplasms - diagnostic imaging | Head and Neck Neoplasms - therapy | Neoplasm Recurrence, Local | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Tumor Burden | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Radiography | Disease-Free Survival | Analysis of Variance | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Neoplasm Staging | Hypopharyngeal Neoplasms - diagnostic imaging | Medical colleges | Care and treatment | Nuclear radiation | Patient outcomes | Oncology, Experimental | Research | Radiotherapy | Tumors | Cancer | HEAD | PATIENTS | NEOPLASMS | FAILURES | METASTASES | LARYNX | COMPUTERIZED TOMOGRAPHY | PLANNING | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | COMBINED THERAPY | HAZARDS
Journal Article